B
Bull
Bull · 25%APDN
$0.90
Scenario price
$5.620
+1.777 (+31.62%)At close
Loading chart…
- High
- 5.870
- Open
- 4.620
- VWAP
- 5.37
- Vol
- 2.88M
- Mkt Cap
- 3.71M
- Low
- 4.610
- Amount
- 15.45M
- EV/EBITDA, TTM
- 0.00
Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
Analyst Ratings (1)
Buy
1 Buy
0 Hold
0 Sell
Current: 5.62
Low
—
Average
—
High
—
HC Wainwright & Co.
Strong Buy
$1.5
2024-06-10
HC Wainwright & Co.
2024-06-10
Price Target
$1.5
Strong Buy
HC Wainwright & Co.
Strong Buy
$7
2024-05-13
HC Wainwright & Co.
2024-05-13
Price Target
$7
Strong Buy
HC Wainwright & Co.
Strong Buy
$30
2024-02-09
HC Wainwright & Co.
2024-02-09
Price Target
$30
Strong Buy
HC Wainwright & Co.
Strong Buy
$40
2023-12-08
HC Wainwright & Co.
2023-12-08
Price Target
$40
Strong Buy
HC Wainwright & Co.
Strong Buy
$80
2023-08-24
HC Wainwright & Co.
2023-08-24
Price Target
$80
Strong Buy
Valuation Metrics
The current forward P/E ratio for Applied DNA Sciences Inc (APDN) is -0.03, compared to its 5-year average forward P/E of -1.67.
Alphio AI Price Scenarios for APDN
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Events Timeline
News
9.009-30BenzingaWolfspeed Shares Surge Over 50%; Check Out 20 Stocks Making Moves in Premarket Trading
8.509-29NewsfilterApplied DNA Sciences Unveils Private Placement of Up to $58 Million to Launch BNB Treasury Strategy and Generate Native Yield for BNB
8.507-01BenzingaWhy Thumzup Media Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
5.006-17SeekingAlphaApplied DNA Chairperson and CEO James A. Hayward resigns
- 9.006-01TipRanks
Upcoming Stock Splits This Week (June 2 to June 6) – Stay Invested
APDN FAQ — answered by Alphio AI
Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services. It operates in the Healthcare sector (SERVICES-TESTING LABORATORIES industry).
1 analysts cover APDN: 1 rate it Buy, 0 Hold and 0 Sell.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.